| 7th Jan 2025 7:00 am |
RNS |
Update Potential Combination of Poolbeg & HOOKIPA |
| 6th Jan 2025 10:27 am |
RNS |
Form 8.5 (EPT/NON-RI) |
| 6th Jan 2025 10:19 am |
GNW |
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc |
| 3rd Jan 2025 11:40 am |
RNS |
Form 8.5 (EPT/NON-RI) |
| 3rd Jan 2025 11:34 am |
GNW |
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc |
| 2nd Jan 2025 7:00 am |
RNS |
Combination of Poolbeg and HOOKIPA Pharma Inc. |
| 20th Nov 2024 7:00 am |
RNS |
POLB 001 Patent Granted in United States |
| 18th Sep 2024 7:00 am |
RNS |
Interim results for the six months to 30 June 2024 |
| 12th Aug 2024 1:28 pm |
RNS |
Holding(s) in Company |
| 26th Jul 2024 7:00 am |
RNS |
Voluntary Delisting from OTCQB Market |
| 10th Jul 2024 7:00 am |
RNS |
Notification of Major Holdings |
| 2nd Jul 2024 7:00 am |
RNS |
Change of Registered Address |
| 17th Jun 2024 8:38 am |
RNS |
Result of AGM |
| 9th May 2024 7:00 am |
RNS |
Annual Report & AGM Notice |
| 1st May 2024 7:00 am |
RNS |
Significant POLB 001 Patent Granted in USA |
| 30th Apr 2024 7:02 am |
RNS |
Appointment of Joint Broker |
| 30th Apr 2024 7:01 am |
RNS |
Option Agreement to Acquire Orphan Drug Candidate |
| 30th Apr 2024 7:00 am |
RNS |
Results for the year ended 31 December 2023 |
| 29th Apr 2024 7:00 am |
RNS |
TR-1: Notification of major holdings |
| 22nd Feb 2024 7:00 am |
RNS |
Director/PDMR Shareholding |
| 19th Feb 2024 1:42 pm |
RNS |
Director Share Purchase |
| 15th Feb 2024 7:00 am |
RNS |
Board Role Change and Launch of EIP |
| 17th Jan 2024 7:00 am |
RNS |
Further data shows POLB001 potential in cancer CRS |
| 20th Dec 2023 7:00 am |
RNS |
RSV AI Drug Candidate Analysis Update |
| 11th Dec 2023 7:00 am |
RNS |
POLB 001 Data Presented at ASH |
| 30th Nov 2023 7:00 am |
RNS |
Directorate Change |
| 21st Nov 2023 7:00 am |
RNS |
Immunomodulator II patent granted in Japan |
| 16th Nov 2023 7:00 am |
RNS |
POLB 001 LPS Trial Data to be Presented at IUIS |
| 9th Nov 2023 7:00 am |
RNS |
Former Amryt Pharma Leadership Team join Poolbeg |
| 3rd Nov 2023 7:05 am |
RNS |
POLB001 Data to be Presented at ASH Annual Meeting |
| 1st Nov 2023 7:00 am |
RNS |
POLB 001 Oncology Programme Update Meeting |
| 26th Oct 2023 7:00 am |
RNS |
SAB Endorses Influenza Drug Targets |
| 17th Oct 2023 7:00 am |
RNS |
Poolbeg Partners with a Nasdaq-Listed Biopharma |
| 29th Sep 2023 7:00 am |
RNS |
Favourable Conclusion of Patent Opposition |
| 20th Sep 2023 7:00 am |
RNS |
Immunomodulator I Patent Portfolio Strengthened |
| 19th Sep 2023 7:00 am |
RNS |
Immunomodulator I Patent Opposition Withdrawal |
| 13th Sep 2023 7:00 am |
RNS |
Interim results for the six months to 30 June 2023 |
| 29th Jun 2023 7:00 am |
RNS |
AI led programme identifies influenza drug targets |
| 22nd Jun 2023 7:00 am |
RNS |
Oral Vaccine Programme Moves Forward |
| 24th May 2023 7:00 am |
RNS |
Board Appointment |
